Actions of serotonin antagonists on dog coronary artery.
Actions of serotonin antagonists on dog coronary artery.
复制标题
血清素拮抗剂对狗冠状动脉的作用。
DOI:
10.1016/0014-2999(82)90346-6
复制
发表时间:
1982
影响因子:
5
通讯作者:
J. Angus
中科院分区:
文献类型:
--
作者:
R. Brazenor;J. Angus
Serotonin released from platelets may initiate coronary vasopasm in patients with variant angina. If this hypothesis is correct, serotonin antagonists without constrictor activity may be useful in this form of angina. We have investigated drugs classified as serotonin antagonists on dog circumflex coronary artery ring segments in vitro. Ergotamine, dihydroergotamine, bromocriptine, lisuride, ergometrine, ketanserin, trazodone, cyproheptadine and pizotifen caused non-competitive antagonism of serotonin concentration-response curves. In addition, ketanserin, trazodone, bromocriptine and pizotifen inhibited noradrenaline responses in concentrations similar to those required for serotonin antagonism. All drugs with the exception of ketanserin, cyproheptadine and pizotifen showed some degree of intrinsic constrictor activity. Methysergide antagonized responses to serotonin competitively but also constricted the coronary artery. The lack of a silent competitive serotonin antagonist precludes a definite characterization of coronary serotonin receptors at this time. However, the profile of activity observed for the antagonist drugs in the coronary artery differs from that seen in other vascular tissues. Of the drugs tested, ketanserin may be the most useful in variant angina since it is a potent 5HT antagonist, lacks agonist activity and has α-adrenoceptor blocking activity.